Expectant therapy for early Group B Streptococcus onset septicemia must provide coverage against other microrganisms, such as L. Monocytogenes, H. Influenzae and S. Pneumoniae. It is possible to administer a combination of antimicrobial agents with activity against all or the most likely pathogens. Thus initial expectant therapy includes a broad spectrum semisynthetic penicillin (e.g. ampicillin) and an aminoglycoside (e.g. netilmicin). Vancomycin, teicoplanin and cefotaxime may also be used. Supportive therapy consists of temperature control, i.v. administration of fluids, acid-base balance and electrolytes monitoring, seizures control and ventilation. I.V. immunoglobulins, granulocyte and serum transfusion are also used. The G-Golony Stimulating Factor (G-CSF, filgastrim) usage is also reported.
|Translated title of the contribution||Treatment of group B streptococcus neonatal septicemia|
|Number of pages||2|
|Journal||Pediatria Medica e Chirurgica|
|Publication status||Published - 1995|
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health